Role of expectations in health

Current Opinion in Psychiatry

Volumn 24, Issue 2, 2011, Pages 149-155

  Colloca, Luana ^a   Miller, Franklin G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

clinical outcomes; conditioning; nocebo effect; placebo effect; psychiatry; verbal suggestion

Indexed keywords

ANTIDEPRESSANT AGENT; DIAZEPAM; FLUOXETINE; PLACEBO;

ARTICLE; CLINICAL PRACTICE; CLINICAL STUDY; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); DEPRESSION; EXPECTATION; HEALTH; HUMAN; LABORATORY TEST; MEDICAL RESEARCH; MENTAL DISEASE; PATHOLOGY; PATIENT CARE; PLACEBO EFFECT; PSYCHIATRY; RANDOMIZED CONTROLLED TRIAL; STUDY DESIGN;

CLINICAL TRIALS AS TOPIC; HUMANS; MENTAL DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PLACEBOS; TREATMENT OUTCOME;

EID: 79951576909     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328343803b     Document Type: Article

References (54)

1. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet 2010; 375:686-695.
2. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron 2008; 59:195-206. (Pubitemid 352033692)
3. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 2008; 59:565-590.
4. Kirsch I. Response expectancy as a determinant of experience and behavior. Am Psychol 1985; 40:1189-1202.
5. Kirsch I. Changing expectations: a key to effective psychotherapy. Belmont, California: Brooks/Cole; 1990.
6. Kirsch I. Conditioning, expectancy, and the placebo effect: comment on Stewart-Williams and Podd (2004). Psychol Bull 2004; 130:31-33; discussion 344-345.
7. Stewart-Williams S, Podd J. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull 2004; 130:324-340. (Pubitemid 38317814)
8. Benedetti F, Pollo A, Lopiano L, et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003; 23:4315-4323. (Pubitemid 36958452)
9. Dennett DC. Consciousness explained. New York: Little, Brown; 1991.
10. Gil M, Menzel R, De Marco RJ. Does an insect s unconditioned response to sucrose reveal expectations of reward? PLoS One 2008; 3:e2810.
11. Colloca L, Petrovic P, Wager TD, et al. How the number of learning trials affects placebo and nocebo responses. Pain 2010; 151:430-439.
12. Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain 2008; 136:211-218.
13. Colloca L, Tinazzi M, Recchia S, et al. Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain 2008; 139:306-314.
14. Colloca L, Benedetti F. Placebo analgesia induced by social observational learning. Pain 2009; 144:28-34.
15. Colloca L, Benedetti F. How prior experience shapes placebo analgesia. Pain 2006; 124:126-133. (Pubitemid 44176203)
16. Price DD, Milling LS, Kirsch I, et al. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 1999; 83:147-156. (Pubitemid 29479272)
17. Colagiuri B. Participant expectancies in double-blind randomized placebocontrolled trials: potential limitations to trial validity. Clin Trials 2010; 7:246-255.
18. Sneed JR, Rutherford BR, Rindskopf D, et al. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 2008; 16:65-73.
19. Leuchter AF, Cook IA, Witte EA, et al. Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 2002; 159:122-129. (Pubitemid 41070737)
20. Leuchter AF, Morgan M, Cook IA, et al. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl) 2004; 177:15-22. (Pubitemid 40109910)
21. Mayberg HS, Silva JA, Brannan SK, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002; 159:728-737. (Pubitemid 34465045)
22. Furmark T, Appel L, Henningsson S, et al. A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci 2008; 28:13066-13074.
23. Volkow ND, Wang GJ, Ma Y, et al. Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in nondrug abusing subjects. Neuroimage 2006; 32:1782-1792. (Pubitemid 44332269)
24. Volkow ND, Wang GJ, Ma Y, et al. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 2003; 23:11461-11468. (Pubitemid 37549703)
25. Leuchter AF, McCracken JT, Hunter AM, et al. Monoamine oxidase a and catechol-O-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol 2009; 29:372-377.
26. Mayberg HS. Defining the neural circuitry of depression: toward a new nosology with therapeutic implications. Biol Psychiatry 2007; 61:729-730. (Pubitemid 46343724)
27. Rohsenow DJ, Marlatt GA. The balanced placebo design: methodological considerations. Addict Behav 1981; 6:107-122. (Pubitemid 11050255)
28. Metrik J, Rohsenow DJ, Monti PM, et al. Effectiveness of a marijuana expectancy manipulation: piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol 2009; 17:217-225.
29. Colloca L, Benedetti F, Porro CA. Experimental designs and brain mapping approaches for studying the placebo analgesic effect. Eur J Appl Physiol 2008; 102:371-380.
30. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002; 287: 1840-1847. (Pubitemid 34303629)
31. Sotsky SM, Glass DR, Shea MT, et al. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 1991; 148:997-1008.
32. Andrews G. Placebo response in depression: bane of research, boon to therapy. Br J Psychiatry 2001; 178:192-194. (Pubitemid 32183598)
33. Rutherford BR, Rose SA, Sneed JR, Roose SP. Study design affects participant expectations: a survey. J Clin Psychopharmacol 2009; 29: 179-181.
34. Rutherford BR, Sneed JR, Roose SP. Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom 2009; 78:172-181.
35. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5:e45.
36. Rief W, Nestoriuc Y, Weiss S, et al. Meta-analysis of the placebo response in antidepressant trials. J Affect Disord 2009; 118:1-8.
37. Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol 2009; 19:34-40.
38. Posternak MA, Zimmerman M. Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis. Br J Psychiatry 2007; 190:287-292. (Pubitemid 46580676)
39. Krogsboll LT, Hrobjartsson A, Gotzsche PC. Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol 2009; 9:1.
40. Krell HV, Leuchter AF, Morgan M, et al. Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry 2004; 65:1174-1179.
41. McRae C, Cherin E, Yamazaki TG, et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry 2004; 61:412-420. (Pubitemid 38451551)
42. Linde K, Witt CM, Streng A, et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 2007; 128:264-271. (Pubitemid 46367430)
43. Juliano LM, Brandon TH. Effects of nicotine dose, instructional set, and outcome expectancies on the subjective effects of smoking in the presence of a stressor. J Abnorm Psychol 2002; 111:88-97. (Pubitemid 34150826)
44. Wise RA, Bartlett SJ, Brown ED, et al. Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol 2009; 124:436-444; 444e1-444e8.
45. Sandler AD, Bodfish JW. Open-label use of placebos in the treatment of ADHD: a pilot study. Child Care Health Dev 2008; 34:104-110.
46. Sandler AD, Glesne CE, Bodfish JW. Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder? J Dev Behav Pediatr 2010; 31:369-375.
47. Colloca L, Benedetti F. Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci 2005; 6:545-552. (Pubitemid 40942821)
48. Benedetti F. How the doctor s words affect the patient s brain. Eval Health Prof 2002; 25:369-386. (Pubitemid 36950484)
49. Di Blasi Z, Kleijnen J. Context effects. Powerful therapies or methodological bias? Eval Health Prof 2003; 26:166-179. (Pubitemid 36583431)
50. Miller FG, Colloca L, Kaptchuk TJ. The placebo effect: illness and interpersonal healing. Perspect Biol Med 2009; 52:518-539.
51. Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: a role for nonspecific activation of endogenous opioids. Pain 2001; 90:205-215. (Pubitemid 32162942)
52. Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 1995; 346:1231.
53. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson s disease. Lancet Neurol 2004; 3:679-684. (Pubitemid 39370638)
54. Levine JD, Gordon NC. Influence of the method of drug administration on analgesic response. Nature 1984; 312:755-756. (Pubitemid 15195921)